Jeff brings almost 30 years of drug development and regulatory experience to Exavir from US FDA, where he was most recently Deputy Director of the Division of Antivirals. Jeff was the author/co-author for 10 Guidance Documents for Industry addressing HIV, HBV, HCV, HDV, Influenza, PEPFAR, CMV, RSV.